: European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums
European drugmakers announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums
Our call of the day comes from a CIO's chat with another CIO who says the Fed doesn't think big investors haven't seen enough of...
Treasury yields bounce back from lowest levels since mid-December as investors monitor China's reopening and await this week's U.S. inflation data
Ocugen Inc. stock OCGN rallied 16% in premarket trade Monday, after the biopharma company announced positive results in a trial of its COVID vaccine Covaxin....
China has suspended or closed the social media accounts of more than 1,000 critics of the government’s COVID response, as the country roll backs harsh...
Lululemon Athletica Inc.LULU revised its fourth-quarter guidance on Monday by raising its revenue guidance. tweaking its per-share earnings guidance to a tighter range and lowering...
Live Nation Entertainment Inc. LYV said Monday it has launched an offering of $850 million of convertible bonds due 2029. Part of the proceeds will...
Rite Aid Corp. RAD said Monday its board has named Elizabeth Burr, a former Humana Inc.HUM executive, as interim chief executive, replacing Heyward Donigan, who...
Tilray Brands Inc. shares fell 3.7% in premarket trades Monday after the cannabis company said it swung to a second-quarter loss. Tilray posted a second-quarter...